Surgery Partners (SGRY) Net Income towards Common Stockholders (2016 - 2025)
Surgery Partners (SGRY) has disclosed Net Income towards Common Stockholders for 12 consecutive years, with $29.0 million as the latest value for Q4 2025.
- Quarterly Net Income towards Common Stockholders rose 162.23% to $29.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $98.9 million through Dec 2025, up 691.2% year-over-year, with the annual reading at $98.9 million for FY2025, 691.2% up from the prior year.
- Net Income towards Common Stockholders hit $29.0 million in Q4 2025 for Surgery Partners, up from $25.3 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $57.7 million in Q2 2023 to a low of -$46.6 million in Q4 2024.
- Historically, Net Income towards Common Stockholders has averaged $5.5 million across 5 years, with a median of $3.8 million in 2023.
- Biggest five-year swings in Net Income towards Common Stockholders: tumbled 23300.0% in 2022 and later soared 1925.0% in 2024.
- Year by year, Net Income towards Common Stockholders stood at -$100000.0 in 2021, then crashed by 23300.0% to -$23.4 million in 2022, then surged by 299.57% to $46.7 million in 2023, then crashed by 199.79% to -$46.6 million in 2024, then skyrocketed by 162.23% to $29.0 million in 2025.
- Business Quant data shows Net Income towards Common Stockholders for SGRY at $29.0 million in Q4 2025, $25.3 million in Q3 2025, and $44.9 million in Q2 2025.